Accordingly, Yan et al. confirmed that IDH1 mutations are more frequent in G II–III astrocytomas and oligodendrogliomas and less frequently in GBM, underlining the correlation between the presence of IDH1 mutation and tumor grade [63]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).